Safety, Tolerability and Immunogenicity of Two Different Formulations of MenB Vaccine, When Administered to Healthy Infants

This study has been completed.

Study NCT00433914 Information provided by Novartis

First Received: February 9, 2007 Last Updated: October 22, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	June 2008
Estimated Primary Completion Date:	No date given